NeOnc Technologies Reports Early Clinical Improvement for CNS Cancer Treatment in UAE
What happened
NeOnc Technologies Holdings, Inc. announced early clinical improvement for investigational intranasal NEO100 in a three-year-old boy in Abu Dhabi, United Arab Emirates. The patient, who has an aggressive brain tumor, is reportedly breathing independently without ventilator support and beginning to move his legs following treatment under a Compassionate Care program. These early observations do not establish that NEO100 caused the improvement or predict outcomes for other patients.
From manilatimes.net
Why it matters
The treatment reflects NeOnc Technologies Holdings, Inc.'s work developing therapies for central nervous system cancers. The company is advancing its drug discovery engine through strategic partnerships, board appointments, and acquisitions.
NeOnc Technologies Holdings, Inc. is advancing its drug discovery engine through strategic partnerships, board appointments, and acquisitions.
From manilatimes.net
Who's involved
- Abu DhabiLocation where the compassionate-use treatment was administered
Keep exploring
The entities involved
-
Thomas Chen
researcher
Nothing else this week.